PDCD1 and Hodgkins lymphoma: Indeed, recent immune monitoring studies have shown that circulating cytotoxic granzyme B+, PD-1+ CD4+ T cells, as well as PD-1+ differentiated effector CD8+ T cells are detected in HL patients.